Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity

Journal: Nature Communications

Published: 2018-09-25

DOI: 10.1038/s41467-018-05890-2

Affiliations: 59

Authors: 73

Go to article
Institutions FC
Department of Biomedical Data Science (BMDS), Dartmouth College, United States of America (USA) 0.14
WHO International Agency for Research on Cancer (IARC), France 0.08
Lunenfeld-Tanenbaum Research Institute (LTRI), U of T, Canada 0.04
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.04
National Institute of Occupational Health (STAMI), Norway 0.03
Radboud University Medical Centre (Radboudumc), RU, Netherlands 0.03
Institute of Translational Medicine (ITM), University of Liverpool, United Kingdom (UK) 0.03
Department of Genetic Epidemiology, University of Göttingen, Germany 0.03
UK Markey Cancer Center, United States of America (USA) 0.03
International Organization for Cancer Prevention and Research (IOCPR), Serbia 0.03
Clinical Centre of Serbia, Serbia 0.03
Russian Oncological Scientific Center named after N.N.Blokhin, RAMS, Russia 0.03
Department of Epidemiology, UW, United States of America (USA) 0.02
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0.02
Faculty of Medicine and Health Sciences, UniOvi, Spain 0.02
National Tuberculosis and Lung Disease Research Institute, Poland 0.01
Department of Oncology and Metabolism, The University of Sheffield, United Kingdom (UK) 0.01
School of Health and Related Research (ScHARR), The University of Sheffield, United Kingdom (UK) 0.01
UPMC Hillman Cancer Center (UPCI), United States of America (USA) 0.01
Harvard Department of Environmental Health (EH), United States of America (USA) 0.01
Department of Preventive Medicine, SNU, South Korea 0.01
BC Cancer Agency (BCCA), PHSA, Canada 0.01
Princess Margaret Cancer Centre, U of T, Canada 0.01
Department of Radiation Sciences, UMU, Sweden 0.01
Department of Medical Biosciences, UMU, Sweden 0.01
Department of Cancer Epidemiology, MOFFITT, United States of America (USA) 0.01
Bellvitge Biomedical Research Institute (IDIBELL), Spain 0.01
Department of Clinical Sciences - Lund, LU, Sweden 0.01
WUS Department of Pharmaceutical Sciences, United States of America (USA) 0.01
Department of Environmental Epidemiology, NIOM, Poland 0.01
Swedish Medical Center, United States of America (USA) 0.01
Marius Nasta Institute of Pneumology, Romania 0.01
Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), Poland 0.01
University Hospital Olomouc, Czech Republic 0.01
Department of Public Health and Preventive Medicine, CU, Czech Republic 0.01
Cancer Epidemiology Program, UH Mānoa, United States of America (USA) 0.01
Department of Epidemiology, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Epidemiology, NJMU, China 0.01
Department of Biostatistics, NJMU, China 0.01
Collaborative Innovation Center for Cancer Personalized Medicine, NJMU, China 0.01
Division of Epidemiology, VU, United States of America (USA) 0.01
Skåne University Hospital (SUS), Sweden 0.01
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.01
Ruth and Bruce Rappaport Faculty of Medicine, IIT, Israel 0.01
Clalit National Israeli Cancer Control Center (NICCC), Israel 0.01
Department of Clinical Sciences - Malmö (DCSM), LU, Sweden 0.01
Department of Thoracic Surgery, VU, United States of America (USA) 0.01
LMU-HMGU Chair of Epidemiology, Germany 0
The German Center for Lung Research (DZL), Germany 0
Institute of Epidemiology II (EPI II), HMGU, Germany 0
Translational Lung Research Center Heidelberg (TLRC), Germany 0
Cancer Cluster Salzburg (CCS), Austria 0
TUM Institut für Medizinische Statistik und Epidemiologie (IMSE), Germany 0
Copenhagen University Hospital (CUH), Denmark 0
Gentofte University Hospital, Denmark 0
Herlev University Hospital, Denmark 0
The Copenhagen General Population Study, Denmark 0
Faculty of Health and Medical Sciences, UCPH, Denmark 0

Return